My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Glenmark Pharmaceuticals Ltd

BSE: 532296 NSE: GLENMARK ISIN Demat: 00000070 Group: A Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

627.45

23 Jun 2017 04:01 PM

-0.80

(-0.13 %)

Get 20% Off on Brokerage

Open (Rs.): 629.70
Prev. close (Rs.): 628.25
High (Rs.): 632.00
Low (Rs): 622.30
52W H (Rs.): 993.00
52W L (Rs.): 600.00
Volume (Rs.): 64574

627.05

23 Jun 2017 03:59 PM

-0.05

(-0.01 %)

Get 20% Off on Brokerage

Open (Rs.): 628.90
Prev. close (Rs.): 627.10
High (Rs.): 632.25
Low (Rs): 622.00
52W H (Rs.): 994.00
52W L (Rs.): 600.00
Volume (Rs.): 681994
EPS (Rs.)
BV (Rs.)
PE (x)
Array
P/BV (x)
Div Yield (%)
MCAP (Rs. in Cr)
MCAP (Rs. in Cr)
EV/Sales (x)
EV/EBITDA (x)
FV (Rs.)

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

52 week range ( Rs. )

627.05
600.00
993.00

Share Holding Pattern

 

Holding Values

Promoter % : 47
Foreign % : 35
Public & Others % : 9
Institution % : 6
Corporate % : 3
Grand Total % : 100
 

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

Results

Consolidated Standalone
YearMar-16Mar-15Mar-14Mar-13Mar-12
SOURCES OF FUNDS :
Share Capital28.2227.1327.1227.0927.05
Reserves and Surplus3,028.231,756.362,956.162,735.942,374.58
Total Shareholders Funds3,056.451,783.492,983.282,763.032,401.63
Secured Loans15.5336.69353.320.001,557.04
Unsecured Loans4,049.573,885.162,965.792,849.96780.02
Total Debt4,065.103,921.853,319.112,849.962,337.06
Minority Interest-0.30-0.1913.2824.3625.00
Total Liabilities7,121.255,705.156,315.675,637.354,763.69
APPLICATION OF FUNDS :
Gross Block4,300.543,495.473,833.513,350.962,636.42
Less: Accum. Depreciation1,726.681,480.09742.96528.63413.66
Net Block2,573.862,015.383,090.552,822.332,222.76
Capital Work in Progress542.80477.135.346.25262.86
Investments17.2017.120.000.000.00
Current Assets, Loans and Advances
Inventories1,567.761,269.04932.88843.53787.67
Sundry Debtors2,492.652,511.772,156.341,640.051,243.61
Cash and Bank Balance869.24775.88800.67607.31321.91
Loans and Advances1,830.231,412.531,647.821,251.531,044.62
Less: Current Liab. and Prov.
Current Liabilities2,570.472,556.902,057.981,500.441,109.11
Provisions202.03216.78259.9533.2210.63
Net Current Assets3,987.383,195.543,219.782,808.762,278.07
Miscellaneous Expenses not w/o0.000.000.000.000.00
Total Assets7,121.245,705.176,315.675,637.344,763.69
Contingent Liabilities36.89129.37129.44117.88131.35

Peer Comparision

SelectCompany NameIntradayLTP(Rs.)M. Cap(In Cr.)
Sun Pharmaceuticals Industries Ltd
543.95 166,102.93
Cadila Healthcare Ltd
522.90 46,406.25
Cipla Ltd
541.00 46,359.89
Dr Reddys Laboratories Ltd
2,648.10 43,779.02
Piramal Enterprises Ltd
2,820.60 38,609.79

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.      

Corporate Actions

Entry Date Book Closer Date Record Date Ex. Dividend DateDividend (%)Dividend ValueDividend Type
03-09-201514-09-200914-09-200910-09-200940.000.40Other
03-09-201501-08-201101-08-201128-07-201140.000.40Interim
03-09-201523-07-201223-07-201219-07-2012200.002.00Interim
03-09-201522-07-201322-07-201318-07-2013200.002.00Interim
03-09-201514-07-201414-07-201410-07-2014200.002.00Interim
03-09-201514-09-201514-09-201510-09-2015200.002.00Interim
21-07-201605-08-201605-08-201603-08-2016200.002.00Interim
SR.DateFrom DateTo DateX DatePropa. Ratio
No data found

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

BSE DateNSE DateDate FV 1FV 2
No data found

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

SR. DateFrom DateTo DateX DatePremiumRatio
No data found

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

From DateTo DateDetails
01-08-201111-08-2011Glenmark Pharmaceuticals Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will remain closed from August 01, 2011 to August 11, 2011 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on August 11, 2011 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting i payable.
23-07-201203-08-2012Glenmark Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 23, 2012 to August 03, 2012 (both days inclusive) for the purpose of Payment of Dividend & 34th Annual General Meeting (AGM) of the Company to be held on August 03, 2012.
22-07-201302-08-2013Glenmark Pharmaceuticals Ltd has informed BSE that the Register of Members and the Share Transfer Books of the Company will remain closed from July 22, 2013 to August 02, 2013 (both days inclusive) for the purpose of the Annual Closure for the 35th Annual General Meeting scheduled to be held on August 02, 2013 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
14-07-201425-07-2014A.G.M. & Rs.2.0000 per share(200%)Dividend
14-09-201522-09-2015Rs.2.0000 per share(200%)Dividend & A.G.M. Sc_Code : 432296 632296
05-08-201612-08-2016A.G.M. & Rs.2.0000 per share(200%)Dividend SC-CODE : 632296

Values are based on Consolidated Data as on Mar 2015. All figures are in millions. All values in INR.

Company Facts

Registered AddressB/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai,Maharashtra ,400026
Registrar Karvy Computershare Pvt Ltd
Plot No 17-24,Vittal Rao Nagar,Madhapur,Hyderabad-500081

Telephone91-22-40189999
Fax91-22-40189986
ExchangeListed Mumbai, NSE, Singapore, MCX-SX
IncorporationYear1977
ChairmanGlenn Saldanha
Director
Company SecretoryHarish Kuber
AuditorWalker Chandiok & Co LLP
Face Value1
Market Lot1

Board of Directors

PostName
Additional DirectorB E Saldanha
Additional DirectorD R Mehta
Chairman & Managing DirectorGlenn Saldanha
Company SecretaryHarish Kuber
DirectorB E Saldanha
DirectorRajesh Desai
Director (Corporate Affairs)Cheryl Pinto
Independent DirectorBernard Munos
Independent DirectorBrian W Tempest
Independent DirectorD R Mehta
Independent DirectorJulio F Ribeiro
Independent DirectorMilind Sarwate
Independent DirectorSridhar Gorthi